Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Ophthalmic Genet ; 40(2): 110-117, 2019 04.
Artículo en Inglés | MEDLINE | ID: mdl-30870047

RESUMEN

BACKGROUND: Leber congenital amaurosis (LCA) and early-onset retinal dystrophy (EORD), are primary causes of inherited childhood blindness. Both are autosomal recessive diseases, with mutations in more than 25 genes explaining approximately ~70% of cases. However, the genetic cause for many cases remains unclear. Sequencing studies from genetically isolated populations with increased prevalence of a disorder has proven useful for rare variant studies, making Costa Rica an ideal place to study LCA/EORD genetics. MATERIALS AND METHODS: Twenty-eight affected children (25 LCA, three EORD) and their immediate family members, totaling 52 individuals (30 affected) from 22 families, were sequenced. Whole exome sequencing was performed on all affected individuals. Available parents were analyzed either by whole exome sequencing (WES) or Sanger sequencing to determine transmission. RESULTS: All affected individuals demonstrated compound heterozygous or homozygous mutations in known Inherited Retinal Disease (IRD) associated genes. Twelve variants were identified in at least one individual in three genes, RDH12, RPE65, and USH2A. Four recurrent RPE65 mutations were observed in 97% of individuals and 95% of families. All patients with LCA and two of the three individuals with EORD had biallelic mutations in RPE65; one child with EORD had a homozygous RDH12 mutation. CONCLUSIONS: These data suggest that the majority of LCA/EORD in Costa Rica is due to four founder mutations in RPE65 which have been maintained in this genetically isolated population. This finding is of great clinical significance due to the availability of gene therapy recently approved in the US and European Union for patients with biallelic RPE65 defects.


Asunto(s)
Mutación del Sistema de Lectura , Amaurosis Congénita de Leber/genética , Mutación Missense , Distrofias Retinianas/genética , cis-trans-Isomerasas/genética , Adolescente , Oxidorreductasas de Alcohol/genética , Niño , Preescolar , Costa Rica/epidemiología , Electrorretinografía , Femenino , Efecto Fundador , Humanos , Lactante , Amaurosis Congénita de Leber/epidemiología , Amaurosis Congénita de Leber/fisiopatología , Masculino , Prevalencia , Retina/fisiopatología , Distrofias Retinianas/epidemiología , Distrofias Retinianas/fisiopatología , Secuenciación del Exoma
2.
PLoS One ; 12(5): e0178201, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28542539

RESUMEN

Spider major ampullate silk fibers have been shown to display a unique combination of relatively high fracture strength and toughness compared to other fibers and show potential for tissue engineering scaffolds. While it is not possible to mass produce native spider silks, the potential ability to produce fibers from recombinant spider silk fibers could allow for an increased innovation rate within tissue engineering and regenerative medicine. In this pilot study, we improved upon a prior fabrication route by both changing the expression host and additives to the fiber pulling precursor solution to improve the performance of fibers. The new expression host for producing spidroin protein mimics, protozoan parasite Leishmania tarentolae, has numerous advantages including a relatively low cost of culture, rapid growth rate and a tractable secretion pathway. Tensile testing of hand pulled fibers produced from these spidroin-like proteins demonstrated that additives could significantly modify the fiber's mechanical and/or antimicrobial properties. Cross-linking the proteins with glutaraldehyde before fiber pulling resulted in a relative increase in tensile strength and decrease in ductility. The addition of ampicillin into the spinning solution resulted in the fibers being able to inhibit bacterial growth.


Asunto(s)
Materiales Biomiméticos , Fibroínas/biosíntesis , Leishmania/metabolismo , Ampicilina/farmacología , Antibacterianos/farmacología , Materiales Biomiméticos/farmacología , Reactores Biológicos , Western Blotting , Reactivos de Enlaces Cruzados/química , Escherichia coli , Fibroínas/química , Fibroínas/farmacología , Fibroínas/ultraestructura , Glutaral/química , Leishmania/genética , Industria Manufacturera , Ensayo de Materiales , Microscopía Electrónica de Rastreo , Proyectos Piloto , Proteínas Recombinantes/biosíntesis , Proteínas Recombinantes/química , Proteínas Recombinantes/farmacología , Proteínas Recombinantes/ultraestructura , Soluciones , Resistencia a la Tracción
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA